Investing Profile

Chris Garabedian

InvestorVC
CEO, Xontogeny and Portfolio Manager, PXV Fund
perceptivelife.com/team/Boston, Massachusetts
Photo of Chris Garabedian, Investor at Perceptive Advisors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $10.0M
$1M
18
CompanyStageDateRound SizeTotal Raised
Delve Bio
Series AJun 2023$35M
$35M
Tellus Therapeutics
Series ADec 2022$35M
SeedMay 2021$2M
$37M
Peroxitech Therapeutics
Series ADec 2022$25M
SeedMay 2021
$25M
PolyCore Therapeutics
SeedApr 2022
$500K
VivoSense
Series AMar 2022$25M
$25M
Nephraegis Therapeutics
SeedMay 2021
Shifa Biomedical
SeedMay 2021
Juno Diagnostics
Series AMay 2021$25M
$25M
Co-investors: Nandeet Mehta (Afore Capital), Rajat Bhageria (Afore Capital), Milad Alucozai (BoxOne Ventures)